Clover Health Investments, Corp vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
5.3
Bearish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
CLOV
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ currently unprofitable (-4% margin).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $2.82 (+3.9%)
3 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
CLOV
PFE
—
Trailing P/E
19.4×
30.1×
Forward P/E
9.4×
-4.4%
Profit Margin
12.4%
18.5%
Gross Margin
75.8%
-26.3%
ROE
8.9%
44.7%
Revenue Growth
-1.2%
—
Earnings Growth
—
2.25
Beta
0.39
—
Price / Book
—
$1.4B
Market Cap
$149.8B
$2 – $4
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →